A new study suggests GLP-1 class weight-loss drugs may lower cancer risk in people with diabetes. It looked at 170,000 patient records, and found there’s a slightly lower risk of obesity-related cancers in U.S. adults with diabetes who took these popular medications. Katherine Ward has this story and more in Health Matters for Friday May 23, 2025.
Health Matters
Health Matters: GLP-1 drugs may lower cancer risk, study shows
More Videos
-
Health Matters: Doctors sue RFK Jr. over vaccine policy changes
-
Health Matters: High blood pressure medication recalled
-
Health Matters: Ontario measles cases trending downward
-
Health Matters: WHO pushing for 50 per cent tax hike on tobacco, alcohol, and sugary drinks
-
Health Matters: Wojcicki’s nonprofit approved to buy 23andMe
-
Health Matters: Concern over measles spreading within Canada this summer
You are viewing an .
View Original Article